Crossref journal-article
Springer Science and Business Media LLC
Nature Genetics (297)
Bibliography

Rosenbauer, F., Owens, B. M., Yu, L., Tumang, J. R., Steidl, U., Kutok, J. L., Clayton, L. K., Wagner, K., Scheller, M., Iwasaki, H., Liu, C., Hackanson, B., Akashi, K., Leutz, A., Rothstein, T. L., Plass, C., & Tenen, D. G. (2005). Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nature Genetics, 38(1), 27–37.

Authors 17
  1. Frank Rosenbauer (first)
  2. Bronwyn M Owens (additional)
  3. Li Yu (additional)
  4. Joseph R Tumang (additional)
  5. Ulrich Steidl (additional)
  6. Jeffery L Kutok (additional)
  7. Linda K Clayton (additional)
  8. Katharina Wagner (additional)
  9. Marina Scheller (additional)
  10. Hiromi Iwasaki (additional)
  11. Chunhui Liu (additional)
  12. Björn Hackanson (additional)
  13. Koichi Akashi (additional)
  14. Achim Leutz (additional)
  15. Thomas L Rothstein (additional)
  16. Christoph Plass (additional)
  17. Daniel G Tenen (additional)
References 50 Referenced 193
  1. Kondo, M., Weissman, I.L. & Akashi, K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661–672 (1997). (10.1016/S0092-8674(00)80453-5) / Cell by M Kondo (1997)
  2. Rothstein, T.L. Cutting edge commentary: two B-1 or not to be one. J. Immunol. 168, 4257–4261 (2002). (10.4049/jimmunol.168.9.4257) / J. Immunol. by TL Rothstein (2002)
  3. Berland, R. & Wortis, H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20, 253–300 (2002). (10.1146/annurev.immunol.20.100301.064833) / Annu. Rev. Immunol. by R Berland (2002)
  4. Herzenberg, L.A. B-1 cells: the lineage question revisited. Immunol. Rev. 175, 9–22 (2000). (10.1111/j.1600-065X.2000.imr017520.x) / Immunol. Rev. by LA Herzenberg (2000)
  5. Tenen, D.G., Hromas, R., Licht, J.D. & Zhang, D.E. Transcription factors, normal myeloid development, and leukemia. Blood 90, 489–519 (1997). (10.1182/blood.V90.2.489) / Blood by DG Tenen (1997)
  6. Orkin, S.H. Diversification of haematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1, 57–64 (2000). (10.1038/35049577) / Nat. Rev. Genet. by SH Orkin (2000)
  7. Moreau-Gachelin, F., Tavitian, A. & Tambourin, P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331, 277–280 (1988). (10.1038/331277a0) / Nature by F Moreau-Gachelin (1988)
  8. Moreau-Gachelin, F. et al. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol. Cell. Biol. 16, 2453–2463 (1996). (10.1128/MCB.16.5.2453) / Mol. Cell. Biol. by F Moreau-Gachelin (1996)
  9. Scott, E.W., Simon, M.C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573–1577 (1994). (10.1126/science.8079170) / Science by EW Scott (1994)
  10. McKercher, S.R. et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647–5658 (1996). (10.1002/j.1460-2075.1996.tb00949.x) / EMBO J. by SR McKercher (1996)
  11. Kim, H.G. et al. The ETS-family transcription factor, PU.1, is necessary for the maintenance of fetal liver hematopoietic stem cells. Blood 104, 3894–3900 (2004). (10.1182/blood-2002-08-2425) / Blood by HG Kim (2004)
  12. Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600 (2005). (10.1182/blood-2005-03-0860) / Blood by H Iwasaki (2005)
  13. Anderson, M.K., Weiss, A.H., Hernandez-Hoyos, G., Dionne, C.J. & Rothenberg, E.V. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 16, 285–296 (2002). (10.1016/S1074-7613(02)00277-7) / Immunity by MK Anderson (2002)
  14. DeKoter, R.P. & Singh, H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288, 1439–1441 (2000). (10.1126/science.288.5470.1439) / Science by RP DeKoter (2000)
  15. Dahl, R. et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat. Immunol. 4, 1029–1036 (2003). (10.1038/ni973) / Nat. Immunol. by R Dahl (2003)
  16. Rosenbauer, F. et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 36, 624–630 (2004). (10.1038/ng1361) / Nat. Genet. by F Rosenbauer (2004)
  17. Rosenbauer, F., Koschmieder, S., Steidl, U. & Tenen, D.G. Effect of transcription factor concentrations on leukemic stem cells. Blood 106, 1519–1524 (2005). (10.1182/blood-2005-02-0717) / Blood by F Rosenbauer (2005)
  18. Li, Y. et al. Regulation of the PU.1 gene by distal elements. Blood 98, 2958–2965 (2001). (10.1182/blood.V98.10.2958) / Blood by Y Li (2001)
  19. Okuno, Y. et al. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Mol. Cell. Biol. 25, 2832–2845 (2005). (10.1128/MCB.25.7.2832-2845.2005) / Mol. Cell. Biol. by Y Okuno (2005)
  20. Rodriguez, C.I. et al. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25, 139–140 (2000). (10.1038/75973) / Nat. Genet. by CI Rodriguez (2000)
  21. Morris, D.L. & Rothstein, T.L. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J. Exp. Med. 177, 857–861 (1993). (10.1084/jem.177.3.857) / J. Exp. Med. by DL Morris (1993)
  22. Boes, M. et al. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160, 4776–4787 (1998). (10.4049/jimmunol.160.10.4776) / J. Immunol. by M Boes (1998)
  23. Stall, A.M. et al. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc. Natl. Acad. Sci. USA 85, 7312–7316 (1988). (10.1073/pnas.85.19.7312) / Proc. Natl. Acad. Sci. USA by AM Stall (1988)
  24. Ceredig, R. & Rolink, T. A positive look at double-negative thymocytes. Nat. Rev. Immunol. 2, 888–897 (2002). (10.1038/nri937) / Nat. Rev. Immunol. by R Ceredig (2002)
  25. Balciunaite, G., Ceredig, R. & Rolink, A.G. The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential. Blood 105, 1930–1936 (2005). (10.1182/blood-2004-08-3087) / Blood by G Balciunaite (2005)
  26. Tetsu, O. & McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422–426 (1999). (10.1038/18884) / Nature by O Tetsu (1999)
  27. van de, W.M., de Lau, W. & Clevers, H. WNT signaling and lymphocyte development. Cell 109 Suppl, S13–S19 (2002). (10.1016/S0092-8674(02)00709-2) / Cell by WM van de (2002)
  28. Amaravadi, L. & Klemsz, M.J. DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol. 18, 875–884 (1999). (10.1089/104454999314737) / DNA Cell Biol. by L Amaravadi (1999)
  29. Holtschke, T. et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307–317 (1996). (10.1016/S0092-8674(00)81348-3) / Cell by T Holtschke (1996)
  30. Watanabe, S. et al. Accessibility to tissue-specific genes from methylation profiles of mouse brain genomic DNA. Electrophoresis 16, 218–226 (1995). (10.1002/elps.1150160137) / Electrophoresis by S Watanabe (1995)
  31. Yu, L. et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat. Genet. 37, 265–274 (2005). (10.1038/ng1521) / Nat. Genet. by L Yu (2005)
  32. Yu, L. et al. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics 84, 647–660 (2004). (10.1016/j.ygeno.2004.06.010) / Genomics by L Yu (2004)
  33. Singh, H., Medina, K.L. & Pongubala, J.M. Gene Regulatory Networks Special Feature: Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA 102, 4949–4953 (2005). (10.1073/pnas.0500480102) / Proc. Natl. Acad. Sci. USA by H Singh (2005)
  34. Fischer, G.M. et al. Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. Cell. Immunol. 213, 62–71 (2001). (10.1006/cimm.2001.1860) / Cell. Immunol. by GM Fischer (2001)
  35. Caligaris-Cappio, F., Gobbi, M., Bofill, M. & Janossy, G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J. Exp. Med. 155, 623–628 (1982). (10.1084/jem.155.2.623) / J. Exp. Med. by F Caligaris-Cappio (1982)
  36. Dakic, A. et al. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 201, 1487–1502 (2005). (10.1084/jem.20050075) / J. Exp. Med. by A Dakic (2005)
  37. Schilham, M.W. et al. Critical involvement of Tcf-1 in expansion of thymocytes. J. Immunol. 161, 3984–3991 (1998). (10.4049/jimmunol.161.8.3984) / J. Immunol. by MW Schilham (1998)
  38. Boxer, R.B., Jang, J.W., Sintasath, L. & Chodosh, L.A. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 6, 577–586 (2004). (10.1016/j.ccr.2004.10.013) / Cancer Cell by RB Boxer (2004)
  39. Costello, J.F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24, 132–138 (2000). (10.1038/72785) / Nat. Genet. by JF Costello (2000)
  40. Suzuki, M. et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. Oncogene (in the press). (10.1038/sj.onc.1209272)
  41. Chan, A.S. et al. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene 22, 6946–6953 (2003). (10.1038/sj.onc.1206799) / Oncogene by AS Chan (2003)
  42. Andres-Barquin, P.J., Hernandez, M.C. & Israel, M.A. Id4 expression induces apoptosis in astrocytic cultures and is down-regulated by activation of the cAMP-dependent signal transduction pathway. Exp. Cell Res. 247, 347–355 (1999). (10.1006/excr.1998.4360) / Exp. Cell Res. by PJ Andres-Barquin (1999)
  43. Hanson, P., Mathews, V., Marrus, S.H. & Graubert, T.A. Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. Exp. Hematol. 31, 159–167 (2003). (10.1016/S0301-472X(02)01021-4) / Exp. Hematol. by P Hanson (2003)
  44. Harada, N. et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18, 5931–5942 (1999). (10.1093/emboj/18.21.5931) / EMBO J. by N Harada (1999)
  45. Schmitt, T.M. & Zuniga-Pflucker, J.C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17, 749–756 (2002). (10.1016/S1074-7613(02)00474-0) / Immunity by TM Schmitt (2002)
  46. Rosenbauer, F. et al. pDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU.1. Blood 103, 4294–4301 (2004). (10.1182/blood-2003-08-2688) / Blood by F Rosenbauer (2004)
  47. Holnthoner, W. et al. Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J. Biol. Chem. 277, 45847–45853 (2002). (10.1074/jbc.M209354200) / J. Biol. Chem. by W Holnthoner (2002)
  48. Kobayashi, S. et al. Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J. Biol. Chem. 277, 33968–33977 (2002). (10.1074/jbc.M203350200) / J. Biol. Chem. by S Kobayashi (2002)
  49. Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409–414 (2003). (10.1038/nature01593) / Nature by T Reya (2003)
  50. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821–9826 (1996). (10.1073/pnas.93.18.9821) / Proc. Natl. Acad. Sci. USA by JG Herman (1996)
Dates
Type When
Created 19 years, 9 months ago (Nov. 27, 2005, 1:58 p.m.)
Deposited 1 year, 6 months ago (Jan. 31, 2024, 11:20 p.m.)
Indexed 1 week, 1 day ago (Aug. 23, 2025, 9:24 p.m.)
Issued 19 years, 9 months ago (Nov. 27, 2005)
Published 19 years, 9 months ago (Nov. 27, 2005)
Published Online 19 years, 9 months ago (Nov. 27, 2005)
Published Print 19 years, 8 months ago (Jan. 1, 2006)
Funders 0

None

@article{Rosenbauer_2005, title={Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1}, volume={38}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/ng1679}, DOI={10.1038/ng1679}, number={1}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Rosenbauer, Frank and Owens, Bronwyn M and Yu, Li and Tumang, Joseph R and Steidl, Ulrich and Kutok, Jeffery L and Clayton, Linda K and Wagner, Katharina and Scheller, Marina and Iwasaki, Hiromi and Liu, Chunhui and Hackanson, Björn and Akashi, Koichi and Leutz, Achim and Rothstein, Thomas L and Plass, Christoph and Tenen, Daniel G}, year={2005}, month=nov, pages={27–37} }